We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.2B
AUM Growth
+$366M
Cap. Flow
+$107M
Cap. Flow %
0.7%
Top 10 Hldgs %
31.7%
Holding
1,371
New
97
Increased
870
Reduced
195
Closed
30

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$266M
2
SUI icon
Sun Communities
SUI
+$169M
3
EXR icon
Extra Space Storage
EXR
+$143M
4
AMT icon
American Tower
AMT
+$103M
5
KRC icon
Kilroy Realty
KRC
+$102M

Sector Composition

Rank Sector Weight
1 Real Estate 55.88%
2 Technology 9.18%
3 Communication Services 4.61%
4 Consumer Discretionary 4.25%
5 Financials 3.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCRR
1276
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$1K ﹤0.01%
131
+68
+108% +$961
JNCE
1277
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1K ﹤0.01%
75
PRVB
1278
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1K ﹤0.01%
106
ATNX
1279
DELISTED
Athenex, Inc. Common Stock
ATNX
$1K ﹤0.01%
9
TCDA
1280
DELISTED
Tricida, Inc. Common Stock
TCDA
$1K ﹤0.01%
110
AKUS
1281
DELISTED
Akouos Inc
AKUS
$1K ﹤0.01%
65
AERI
1282
DELISTED
Aerie Pharmaceuticals
AERI
$1K ﹤0.01%
102
RDUS
1283
DELISTED
Radius Health, Inc.
RDUS
$1K ﹤0.01%
88
EPZM
1284
DELISTED
Epizyme, Inc
EPZM
$1K ﹤0.01%
191
FLXN
1285
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1K ﹤0.01%
109
BDSI
1286
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1K ﹤0.01%
222
ACET icon
1287
Adicet Bio
ACET
$76.7M
$0 ﹤0.01%
4
ADVM
1288
DELISTED
Adverum Biotechnologies
ADVM
$0 ﹤0.01%
18
AFYA icon
1289
Afya
AFYA
$1.32B
-2,075
Closed -$53K
APRE icon
1290
Aprea Therapeutics
APRE
$7.6M
$0 ﹤0.01%
2
AQN icon
1291
PUT
Algonquin Power & Utilities
AQN
$4.68B
-1,103
Closed -$33K
ARDX icon
1292
Ardelyx
ARDX
$1.25B
$0 ﹤0.01%
196
ASMB icon
1293
Assembly Biosciences
ASMB
$507M
$0 ﹤0.01%
6
AUTL
1294
Autolus Therapeutics
AUTL
$386M
$0 ﹤0.01%
74
BEKE icon
1295
KE Holdings
BEKE
$17.7B
-8,550
Closed -$408K
CVAC
1296
DELISTED
CureVac
CVAC
-4,006
Closed -$294K
DBX icon
1297
PUT
Dropbox
DBX
$7.48B
-1,839
Closed -$38K
DOCS icon
1298
Doximity
DOCS
$3.85B
-1,098
Closed -$64K
FHI icon
1299
Federated Hermes
FHI
$4.59B
-6,300
Closed -$214K
FTS icon
1300
Fortis
FTS
$29.7B
-17,000
Closed -$752K

Similar funds

Daiwa Securities Group's Q3 2021 Portfolio in Review

As of Q3 2021, Daiwa Securities Group held 1,371 positions worth $15.2B, up 2.5% from $14.8B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group's Q3 2021 filing shows 97 new, 870 increased, 195 reduced and 30 closed positions. Its largest new stake was Global X Cloud Computing ETF: 500,000 shares worth $14.6M. The largest sale was Equinix, an estimated $266M.

By sector, the portfolio is most concentrated in Real Estate at 56% of assets, down from 59% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q3 2021 buy was Global X Cloud Computing ETF: 500,000 shares worth $14.6M.
  • Daiwa Securities Group added most to Invitation Homes in Q3 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q3 2021 reduction was Equinix, cutting an estimated $266M.
  • Daiwa Securities Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.09M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $15.2B portfolio in Q3 2021.
  • Daiwa Securities Group opened 97 new positions and closed 30 in Q3 2021.
  • Daiwa Securities Group's portfolio value rose 2.5% quarter-over-quarter to $15.2B.

Based on Daiwa Securities Group's 13F filing for Q3 2021, filed 5 Nov 2021.